CALC
CALC
NASDAQ · Pharmaceuticals

Calcimedica Inc

$0.69
-0.02 (-3.44%)
As of Aug 9, 11:01 PM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 7 78%
Hold 2 22%
Sell 0 0%
Price Target
Analyst Price Target +5,239.6% upside
Low Target $29.06
Average Target $36.71
High Target $43.55
Current Price $0.69
Current
$0.69
Target
$36.71
$29.06 $36.71 avg $43.55
Scenario Analysis
Bear Case
$29.06
4,126.9%
Low target
Base Case
$36.71
+5,239.6%
Avg target
Bull Case
$43.55
+6,234.5%
High target
Risk/Reward
1.5x
Balanced
Price in Context
52-Week High
$7.20
-90.5% from high
52-Week Low
$0.46
+49.3% from low
Target vs 52W High
$36.71
+409.9% vs high
Next Earnings Report
Aug 18, 2026
7d
until earnings
EPS Est: $-0.29
Earnings in 7 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +15.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +188.8%